00:00 - Introduction 00:19 - Overview of the Study 01:05 - Importance of the Study and Its Future Impact 01:34 - Details of the Patient Group Studied 02:40 - Study Methodology 03:27 - Key Findings of the Study 04:05 - Why is Long COVID So Tough to Crack? 05:24 - Complement System Activation and Processes 09:07 - Complement System and Long COVID 10:04 - Future Treatment Directions 11:50 - Final Thoughts 13:31 - Closing Remarks
[Music]
if you're affected by long covid there's
a new paper out that you need to be
aware of by Dr felic louu and others
titled large scale phenotyping of
patients with long covid po
hospitalization reveals mechanistic
subtypes of disease but what does this
mean in simple terms and why should you
care the thing is this study has
identified not merely theorized or
suggested that there are people with
long covid who have patterns of
inflammatory markers which can be
detected on a blood sample okay so far
so good but here's the kicker the
patterns seem to correlate with
different subtypes of long covid as well
although the authors are quick to state
that the study was undertaken to better
understand the inflammatory processes
which Drive long covid not to discover
biomarkers of disease thing is that
correlation of long covid subtypes does
strongly suggest that this might be the
first step towards a disease modifying
therapeutic trial potentially now we
know that one in 10 covid-19 cases leads
to a degree of long covid so it's no
surprise that there's an estimated 65
million people worldwide waiting
anxiously for a test which can deliver a
clear insight as to what's going on with
their body and by my reading this study
isn't that yet but I think this study is
probably going to be one of the paper
that we'll look back on as marking a
turning point in our understanding of
long Co so the study was led by Imperial
College London and looked at 657 people
who'd previously been hospitalized due
to covid-19 infections which occurred
more than 3 months prior to the study
now that's important because 3 months is
12 weeks and that's considered to be the
the cut off for where prolonged symptoms
are now indicative of long Co
of those 600 plus patients
426 still had at least one covid symptom
whilst 233 had completely recovered now
on the face of it that's vastly more
than the 10% of patients who developed
long covid which jars with my earlier
statement however the hypothesis for
this difference in symptoms is that this
was not a general population study but
actually was looking at Patients
specific specifically who had been
hospitalized due to covid and that's
important because we're aware that those
patients seem to be a to hire risk of
developing long covid after their
initial infection the team went with a
slightly shotgun style approach so to
speak looking for a wide range of
proteins in fact
368 separate proteins these are specific
ones that are known to be involved in
immunity and inflammation now from my
perspective when I'm dealing with an
individual patient this this isn't the
best approach as essentially you're
throwing everything at the wall to see
what sticks problem is you don't know if
something is stuck because they should
have done or if they've stuck just by
chance given the large number of
patients in this study this greatly
reduces the chances of the team having
picked out so many similar findings
across so many different patients by
chance so I say that so many different
findings what did they actually find
compared to the recover covered patients
the long Co patient still experiencing
symptoms had detectable patterns of
blood markers consistent with immune
activation was ongoing okay we kind of
expected that from the title but what do
they mean when they say immune system
activation the study found two signals
in fact there was one marker of
inflammation of bone marrow cells
specifically myoid cells whose role is
to trigger other white blood cells but
there was also EV evidence of an
activation of the complement system now
these findings specifically that
compliment system activation perhaps
give an idea why long Co has been such a
tough nut crack because if you ask
Medics which lecture was their favorite
at Medical School very few are going to
stick up their hand and say anything to
do with the compliment system and those
doctors who did unsurprisingly became
blood doctors and are working hematology
now I raise that point because when
covid came around it was the respiratory
teams the Intensive Care teams the
cardiologists the A&E and general
practice teams that ended up being the
heroes Who Bore the brunt of the
workload on the ground but that was
because we were dealing with patient
symptoms and it makes sense really if
your patient can't breathe or their
heart is doing something weird you
really want to be talking to the heart
or the lung doctor but now as we're
digging into what's causing that 10% %
of patients to remain ill it appears
that the hematologists and the
immunologists might hold the key
unfortunately these guys and girls are
some of the smartest doctors there are
and unfortunately we don't have enough
of them which maybe why it's taken so
long to get these studies out so the
compliment system is by all accounts
thick textbook type medicine and as a GP
remember I'm a bearer with a very small
brain I'm going to try and break down
what the compliment system does and why
that's relevant to you I suppose the
first part is explaining the name the
complement system is so named as it
complement or enhances the activities of
two specific parts of the immune system
that of antibodies and phagocytic cells
so what happens is literally the body
detects an infection antibodies are
produced and they stick onto identify
markers or antigens on the pathogen this
and triggers a large Cascade of
reactions which complement that antibody
related immune system so whilst it's
nice know where the name comes from how
does activation of the complement system
relate to the second finding from the
study that markers of inflammation from
myoid cells were also elevated why might
that explain the subtypes of long covid
that the authors thought they could
identify in the study oh yes I I've not
gone into that yet but the study
suggested patterns of immune activation
which could potentially differentiate
five different phenotypes or
symptomologies of long covid but we'll
get to that in a moment with regards to
the compliment system there are five
things that happen where the body
notices an infection or damage the
tissues the first is what's called
opsonization so here complement proteins
bind to the surface of an infectious
agent essentially tagging them for death
by the body and this death is achieved
by the immune system attacking those
pathogens with nutrifil and macrofagos
the second bit of the complement system
is a relatively straightforward one
inflammation but what does that mean for
p s basically you get vascular
permeability which allows cells immune
cells to pass into tissues think when
you get an infected wounds when it's
beginning to ooze this is the result of
inflammation triggered by the tissue
injury and the infection the third part
of the compliment system is what's
called membrane attack complex formation
which honestly sounds like something
from a 1980s cartoon and actually might
not be missing the point by that not
because essentially it's a bomb that the
immune system can produce that can be
attached to the side of bacterial
pathogens which then causes the bacteria
to leak and
burst so throughout this complement
activation process we also have another
system going on that's the activation of
an Adaptive immune response basically
this is about the complement system
making blueprints of bacteria viruses
and damaged cells and making that
blueprint available to white blood cells
specifically B cells which leads the B
cell producing more antibodies to help
mopet that infection and then the final
bit of the compliment system is the
cleanup teams you see when we've got an
immune system reaction like this we've
got all these proteins and antibodies
and immune stuff flying around this part
of the compliment system helps clear up
all those leftover weapons of the immune
system meaning we don't get tissue
damage after the infections being dealt
with and I think that is where the light
bulb might go off for some people
so it's fair to say that the complement
system is complex and while lots of
people haven't heard about the
compliment system many are aware of
diseases that occur when it goes wrong
the big names that you might be aware of
are antiphospholipid syndrome rumod
arthritis and as everybody knows from
house lupus one of the things that was
particularly interesting about the
findings from this study as we've just
highlighted the complement system
basically has its own cleanup Cruise and
they're there to terminate activation
and remove leftover ammunition After The
Infection has been dealt with however
with long Co it seems we get a continued
activation of the compliment system and
perhaps a breakdown in the cleanup
cruise and first author Dr Phil L
strongly highlighted that it's
indicative that the range of long covid
symptoms is as a result of active
inflammation and again is that the
compliment system going to Haywire or is
it the cleanup part not
working what we can say is the
information from this paper and that
whole idea that long covid is due to
active inflammation does make sense with
the conversations I have with patients I
mentioned earlier when I highlighted
five symptomologies or phenotypes of
long covid had been identified in the
study I don't think anyone's going to be
surprised to see that they were fatigue
cognitive impairment respiratory issues
gastrointestinal symptoms and also
interesting enough anxiety and
depression However the fact that they
were able to identify pattern which
marked particular symptoms could be key
for tailoring treatments to patients I
say that because we see this with
antibiotics you basically nuke the
patient's own microbiome whilst treating
that single pathogenic bacteria and in
the shortterm that might cause an up
stomach but we'll actually have lowlevel
lasting effects for up to 3 months after
you've taken those antibiotics when it
comes to looking at ways to potentially
modulate the patient's immune system
which is relatively important we want to
be as careful and as targeted as
possible to reduce the risk of
collateral damage so these patterns
indicating different symptoms or
presentations along covid might mean in
the long term we can tailor specific
treatments to specific patients and
reduce harm from our treatments one of
the big problems with long covid has
been our lack of focus to treatments
there's evidence plenty of evidence of
microclot issues in some patients and we
do see improvements with those patients
when we treat them with
anticoagulation but we haven't been able
to ex conclusively prove what has
triggered that inappropriate clotting in
the first place it may be that ongoing
issues with inflammation are likely to
be one of those triggers for
coagulopathies and now we' have a study
that might not necessarily give us the
specific Target but certainly gives us
is a very good idea of where we need to
keep looking for the answer to which end
the authors of this paper highlighted
might be able to use a series of drugs
called il1 antagonists to treat lco and
I'm sure no one's going to be surprised
to hear that il1 agonists are used for
conditions like severe Advanced
rheumatoid arthritis personally I feel
lco is a spectrum of symptoms related to
coagulation problems inflammatory
problems gut microbiome changes and
possibly allergic mediative responses
but you know what would tie all of these
together an autoimmune system issue such
as what this team are talking about here
but and this is very important the team
of this paper have highlighted that they
can't be sure that the findings in this
paper are applicable to all long covid
patients so we're going to take all of
it not with a grain of salt but with
some por with some caution given the
possibilities that these newly found
blood markers suggest that fatigue in
some covid patients might be responsible
for inflammation it also opens up the
possibility of running this same panel
of tests against patients who might have
been affected with other post viral
fatigues such as me I raised the point
do investigations by Dr Lou's team have
given strong evidence that lco is post
viral INF inflammation unfortunately we
know that such inflammation such as when
it's come from sign bar infections you
know we've said you were fine you had
EBV and now you've got post file fatigue
can be incredibly difficult to counter
but now we've got to Target it might be
much easier for us to direct our medical
Arsenal to identify treatments that
could be directed towards General post
viral information ultimately this to me
was a really important paper and I think
it gives a little bit of Hope to those
patients with long covid so I I hope
this has been a useful uh little
overview for you if you'd like me to do
more um chats uh like this when
interesting papers come across my way
drop drop comments uh down below and
we'll see what we can do with that in
mind take care and we'll see you in the
next one cheer